Listed

Petmed Express Inc: Form 10-Q for the period ended Dec 31, 2019

Filed with the SEC on Jan 28, 2020 and accepted by EDGAR at Jan 28, 2020, 12:01 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2019-12-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue9 months2019-04-01 to 2019-12-31$209.8mus-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
Cost of revenue3 months2019-10-01 to 2019-12-31$42.2mus-gaap:CostOfGoodsAndServicesSold
Cost of revenue9 months2019-04-01 to 2019-12-31$150.3mus-gaap:CostOfGoodsAndServicesSold
Gross profit3 months2019-10-01 to 2019-12-31$17.7mus-gaap:GrossProfit
Gross profit9 months2019-04-01 to 2019-12-31$59.6mus-gaap:GrossProfit
Operating income3 months2019-10-01 to 2019-12-31$7.9mus-gaap:OperatingIncomeLoss
Operating income9 months2019-04-01 to 2019-12-31$22.5mus-gaap:OperatingIncomeLoss
Income tax3 months2019-10-01 to 2019-12-31$1.8mus-gaap:IncomeTaxExpenseBenefit
Income tax9 months2019-04-01 to 2019-12-31$5.9mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2019-10-01 to 2019-12-31$6.8mus-gaap:NetIncomeLoss
Net income9 months2019-04-01 to 2019-12-31$18.8mus-gaap:NetIncomeLoss
Diluted EPS3 months2019-10-01 to 2019-12-31$0.34us-gaap:EarningsPerShareDiluted
Diluted EPS9 months2019-04-01 to 2019-12-31$0.94us-gaap:EarningsPerShareDiluted
Basic EPS3 months2019-10-01 to 2019-12-31$0.34us-gaap:EarningsPerShareBasic
Basic EPS9 months2019-04-01 to 2019-12-31$0.94us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2019-10-01 to 2019-12-3119,994,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)9 months2019-04-01 to 2019-12-3120,071,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow9 months2019-04-01 to 2019-12-31$21.6mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure9 months2019-04-01 to 2019-12-31$1.8mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Dividends paid9 months2019-04-01 to 2019-12-31$16.4mus-gaap:PaymentsOfDividendsCommonStock
Share repurchases9 months2019-04-01 to 2019-12-31$11.5mus-gaap:PaymentsForRepurchaseOfCommonStock
Cash and equivalentsAt period end2019-12-31$92.4mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2019-12-31$122.8mus-gaap:AssetsCurrent
Total assetsAt period end2019-12-31$149.5mus-gaap:Assets
Current liabilitiesAt period end2019-12-31$20.7mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2019-12-31$21.8mus-gaap:Liabilities
Shareholders' equityAt period end2019-12-31$127.7mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001437749-20-001273. Last ingested by Listed: Nov 13, 2026, 14:26 ET. Listed shows no prices and gives no investment advice.